Drug Profile
GX 127
Alternative Names: GX-127Latest Information Update: 30 Sep 2013
Price :
$50
*
At a glance
- Originator Genexine
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 02 Aug 2012 No development reported - Phase-I for HIV infections in South Korea (unspecified route)
- 02 Aug 2010 Phase-I clinical trials in HIV infections in South Korea (unspecified route)